Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
| ▸ | TUBB | P07437 | 1/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.41 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.41 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11938932 | 0.84 | CYP3A4 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL19681306 | 0.80 | CYP3A4 (0.38) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL13076862 | 0.79 | ALDH1A1 (0.56) | ALDH1A1CYP1A2CYP3A4CYP1A1CYP1B1 | |
| SCHEMBL8117527 | 0.78 | ACHE (0.59) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL1122691 | 0.78 | TUBB4A (0.55) | ALDH1A1CA12CA1CA2CA7 | |
| Difucol Hexamethyl Ether SCHEMBL505203 | 0.77 | CYP1A2 (0.60) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL8750267 | 0.76 | GAA (0.48) | ALDH1A1CA1CA2CYP1A2CYP3A4 | |
| Hydrochloric Acid SCHEMBL5265528 | 0.76 | ALDH1A1 (0.58) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL862161 | 0.74 | ALDH1A1 (0.56) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL686849 | 0.74 | CYP1A2 (0.64) | ALDH1A1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2752935-A1 | DYE-SENSITIZED SOLAR CELL AND SENSITIZING DYE | National Institute for Materials Science (JP) | 2014-07-09 | — | — | EP | disclosed |
| US-8278356-B2 | — | — | 2012-10-02 | — | — | US | disclosed |
| US-20110142765-A1 | NOVEL PHLOROGLUCINOL DERIVATIVES HAVING SELECTIN LIGAND ACTIVITY | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2011-06-16 | — | — | US | disclosed |
| US-7919532-B2 | Chronic onstructive pulmonary disease; adult respiratory distress syndrome; antiinflammatory agents; skin disorders; autoimmune diseases; multiple sclerosis; antihistamines; inflammatory bowel disorders | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2011-04-05 | — | — | US | disclosed |
| US-20080207741-A1 | Novel Hydroxylated Aromatic Compounds | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207741-A1 | Novel Hydroxylated Aromatic Compounds | SELP, SELL, SELE | ALDH1A1 71/4885CA12 3746/4885CA1 4550/4885 |
| US-20110142765-A1 | NOVEL PHLOROGLUCINOL DERIVATIVES HAVING SELECTIN LIGAND ACTIVITY | SELPLG, SELP, SELL | ALDH1A1 431/4885CA12 3936/4885CA1 4744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.